SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$7.91
-0.57%
Mkt Cap $823.17M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$29.33
Range $26.00 – $32.00
Implied Upside
+271.0%
Consensus $29.33 vs current $7.91
NASDAQ·Healthcare·Biotechnology
$7.91
-0.57%
Mkt Cap $823.17M
No recent rating data.
Price Target (8 analysts)
$29.33
Range $26.00 – $32.00
+271.0%
Consensus $29.33 vs current $7.91